Abstract:Analysis of recurrent DNA amplification can lead to the identification of cancer driver genes, but this process is often hampered by the low resolution of existing copy number analysis platforms. Fifty-one breast tumors were profiled for copy number alterations (CNAs) with the high-resolution Affymetrix 500K SNP array. These tumors were also expression-profiled and surveyed for mutations in selected genes commonly mutated in breast cancer (TP53, CDKN2A, ERBB2, KRAS, PIK3CA, PTEN). Combined analysis of common CNAs and mutations revealed putative associations between features. Analysis of both the prevalence and amplitude of CNAs defined regions of recurrent alteration. Compared with previous array comparative genomic hybridization studies, our analysis provided boundaries for frequently altered regions that were approximately one-fourth the size, greatly reducing the number of potential alteration-driving genes. Expression data from matched tumor samples were used to further interrogate the functional relevance of genes located in recurrent amplicons. Although our data support the importance of some known driver genes such as ERBB2, refined amplicon boundaries at other locations, such as 8p11-12 and 11q13.5-q14.2, greatly reduce the number of potential driver genes and indicate alternatives to commonly suggested driver genes in some cases. For example, the previously reported recurrent amplification at 17q23.2 is reduced to a 249 kb minimal region containing the putative driver RPS6KB1 as well as the putative oncogenic microRNA mir-21. High-resolution copy number analysis provides refined insight into many breast cancer amplicons and their relationships to gene expression, point mutations and breast cancer subtype classifications. This article contains Supplementary Material available at http:// www.interscience.wiley.com/jpages/1045-2257/suppmat. (C) 2008 Wiley-Liss, Inc.

Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer

Copy number alterations: a catastrophic orchestration of the breast cancer genome

Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk.

Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns

Somatic Gene Copy Number Alterations in Colorectal Cancer: New Quest for Cancer Drivers and Biomarkers

Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

Systematic Modeling of Risk-Associated Copy Number Alterations in Cancer

The Repertoire of Copy Number Alteration Signatures in Human Cancer

An Integrated Approach to Reveal Mirnas' Impacts on the Functional Consequence of Copy Number Alterations in Cancer

Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach

Genome-wide Somatic Copy Number Alteration Analysis and Database Construction for Cervical Cancer.

High resolution copy number inference in cancer using short-molecule nanopore sequencing

Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells.

The landscape of somatic copy-number alteration across human cancers

High-Resolution Genomic And Expression Analyses Of Copy Number Alterations In Breast Tumors

Signatures of copy number alterations in human cancer

Clinical Significance of Germline Copy Number Variation in Susceptibility of Human Diseases.

Identification and Analysis of Sex-Biased Copy Number Alterations

Gastric Cancer And Gene Copy Number Variation: Emerging Cancer Drivers For Targeted Therapy

The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma